pegcetacoplan
sobi,Apellis Pharmaceuticals
['sobi']
$apls apellis and sobi report new data reinforcing the robust efficacy and safety profile of empaveli (pegcetacoplan) for pnh at eha 2022 congress 45 seconds delayed.
Democratizing insights.

Not investment advice.